In the high-dose group, the insulin resistance was seemingly mediated by increasing glucokinase activity and reducing hepatic glucose output for liver glycogen deposition to enhance glucose utilization accompanying improvement in oral glucose and insulin tolerance. This evidence concerns the gene INS and Insulin resistance.